Investor Ideas #Potcasts
535, #Cannabis News and #Stocks on the Move; (NEO: MGW) (OTCQB: $MGWFF) (TSX: $APHA.TO) (NASDAQ: $APHA) (NASDAQ: $TLRY) (CSE: $AUSA.C)
Delta, Kelowna, BC, February 24, 2021 (Investorideas.com
Newswire) www.Investorideas.com, a global news source covering leading sectors
including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s podcast
edition of cannabis news and
stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
https://www.investorideas.com/Audio/Podcasts/2021/022421-StocksToWatch.mp3
Read
this in full at https://www.investorideas.com/news/2021/cannabis-potcasts/02241MGWFF-APHA-TLRY-AUSA.asp
Hear the investor ideas potcast on Spotify
Hear Investor ideas cannabis potcast on iTunes
Today’s podcast overview/transcript:
Good
afternoon and welcome to another episode of Investorideas.com
"Potcast" featuring cannabis news, stocks to watch as well as
insights from thought leaders and experts.
In
today’s podcast we look at a few public and private company announcements.
Everest
BioPharma International Inc. announced that it has
received, in February 2021, its
notification of Eligible Business corporation ("EBC") under the BC
Venture Capital Act allowing BC
investors a 30% Tax Credit. The Company is presently completing the internal
build-out of its state-of-the art cannabis extraction systems in Kelowna, BC.
The first sales of live rosen and its derivatives are expected in May, 2021.
Everest is installing large capacity
ice water bubble hash solventless processing equipment with ancillary rosen
presses, which also allows the ability for "organic" registration,
adding further value to its products.
Nigel Boast, President and CEO of
Everest BioPharma stated; "Our
registration as an eligible
business corporation "EBC" in BC (attracting a 30% tax credit) will facilitate
funding required for us to fully implement our business plan which firstly
focuses on tolling service fees and then the sale of our proprietary medical
CBD products. Two recent standard processing license sales: Premium 5 with a
similar business model ($40M), and LYF Food ($43M) indicate a high valuation
for Everest.
Rob Hatch, COO of Everest BioPharma
stated; "By processing from frozen, we save our tolling customers time and
money because there is no requirement to trim and dry the product. There are
approximately 147 standard cultivation licenses in Canada without extraction licenses."
Aphria
Inc. (TSX:
APHA) (NASDAQ:
APHA), a leading global cannabis-lifestyle consumer
packaged goods company inspiring and empowering the worldwide community to live
their very best life, and Tilray, Inc.
(NASDAQ:
TLRY), a global pioneer in cannabis research, cultivation,
production and distribution, announced the
launch of the website: www.aphriatilraytogether.com. This
new, dedicated resource seeks to provide
shareholders of both companies with pertinent information, news and
updates leading up to the special meetings of shareholders at which Aphria's
and Tilray's respective shareholders will vote on the resolutions necessary to
implement the proposed business combination of the two companies. The website will also allow shareholders and
other interested parties to register for Transaction updates that are made
publicly available, so they receive information directly to their e-mail
addresses.
As disclosed in the preliminary
joint proxy statement and management information circular filed with regulators
on February 19, 2021, both companies are pleased that the applicable waiting
period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as
amended, has expired in relation to the Transaction. In addition, the companies have received a
no-action letter from the Competition Bureau of Canada in respect of the
Transaction, which confirms that the Competition Bureau does not intend to
challenge the Transaction under the Competition
Act (Canada). The receipt of the HSR
Clearance and the Competition Act Approval are two of the required regulatory
clearances that need to be obtained to satisfy the conditions to closing of the
Transaction. The closing of the Transaction is currently expected to occur in
the second quarter of calendar year 2021.
Irwin D. Simon, Aphria's Chairman and
Chief Executive Officer commented, "The receipt of HSR Clearance and
Competition Act Approval represent a significant step forward in bringing
together these two companies, and we are incredibly pleased that we remain on
track to complete our business combination in the second quarter of calendar
year 2021. Together, Aphria and Tilray
expect to have a robust strategic footprint in Canada and internationally with
the operational scale necessary to compete more effectively in today's
consolidating cannabis market. We believe our strong, flexible balance sheet,
cash position and access to capital will provide us with the ability to
accelerate long-term sustainable growth and deliver attractive returns for
shareholders."
Australis
Capital Inc. (CSE:
AUSA) (OTC:
AUSAF) announced
today that, further to its press release dated January 5,
2021, the Company has entered into a definitive agreement with the principals
of ALPS for the acquisition of 51% of the issued and outstanding shares in
ALPS. The Definitive Agreement has an option permitting the Company to acquire
the remaining 49%. Furthermore, the ALPS Transaction also includes the
appointment of Terry Booth as AUSA's CEO upon completion.
Since its management buyout from
Aurora Cannabis in May 2020, ALPS has rapidly built a blue-chip roster of
global customers and a growing pipeline of potential new deals. ALPS currently
is executing on a number of contracts, including four that were signed and
announced in the past month:
● Aurora
Cannabis - Annual ongoing services contract, multiple locations globally
● Cann
Group - Cannabis facility contract + APIS extended services contract in
Australia
● Multiple
undisclosed cannabis related contracts in the U.S.
● Bluehouse
Greenhouse – 62 acre vegetable facility contract in California, U.S.
● Vertical
Harvest – 200,000 sqft multi-level urban facility contract in Wyoming, U.S.
● Aldershot
Greenhouses – 200,000 sqft facility expansion contract in Ontario, Canada
● 200,000
sqft small plant production facility in Finland
● 20,000
sqft crop research facility in northern U.S.
● Tropica
– facility for the cultivation of aquarium plants in Germany
● McMaster
University, life Science Centre, Ontario, Canada
● Queen,
Denmark – ornamental plants
● Middle
East – large fruit & vegetable facility
The ALPS Transaction, upon closing,
will be immediately accretive to AUSA results, with further material growth
anticipated in the coming months.
Maple
Leaf Green World Inc. (NEO:
MGW)
(OTCQB:
MGWFF)
announced that it has signed an agreement with
Hempacco Co. Inc., a vertically integrated California-based Hemp CBD, CBG R&D,
marketing, and manufacturing company, to develop, manufacture and market its
new brand of CBG Hemp cigarettes.
The Agreement aims to develop a new
CBG hemp cigarette brand for Maple Leaf using their California-grown hemp.
Hempacco will handle all of the research, development, and manufacturing of a
retail-ready 20-pack CBG-rich hemp cigarette brand.
"I’m excited to work with
Hempacco to develop our brand of CBG hemp cigarettes; this is a pivot for our
company after identifying the growing hemp cigarette space and the market
opportunity not only in the USA, but also in Canada and internationally”, said
Raymond Lai, CEO of Maple Leaf, “Our CBG farm is minutes away from Hempacco’s
manufacturing location, which makes it an amazing opportunity to have our own
seed to shelve product and deliver an incredible hemp smokable quality
experience to the consumer,” Raymond concluded.
“It’s been a pleasure working with
Raymond and his team to launch Maple Leaf’s new CBG brand in our quest to
disrupt Tobacco™,” said Sandro Piancone, CEO of Hempacco. “We’re committed to a
fast launch of the CBG hemp cigarette brand and following it up with an
eCommerce portal that integrates picking, packing, and shipping all from one
location close to the Maple Leaf’s farm,” Sandro concluded.
The hemp cigarette private label
manufacturing agreement is for five (5) years consists of two (2) phases. The
first phase is hemp cigarette product development, including Research &
Development, Business Modelling, and hemp cigarette white label Manufacturing
sub-phases. Hempacco will undertake all the necessary work for the three (3)
sub-phases, including packaging and shipping, where Maple Leaf supplies raw
hemp material. Maple Leaf and Hempacco will jointly develop branding and
packaging artwork that Hempacco will manufacture. The second phase is to
establish an e-commerce Strategy, which will expand Maple Leaf’s online and
social media presence by developing a full e-commerce platform. Through the
Company’s new hemp cigarette online store, CBG hemp cigarettes, packaged flower
jars, and subsequent product developments will be available for purchase and
shipped across the United States and Overseas. Both phases will commence
immediately.
Hempacco will invest in the brand by
paying for all the initial start-up costs associated with both phases. Maple
Leaf will contribute to the manufacturing and order processing cost when sales
are made. As compensation for Hempacco’s services, Maple Leaf will pay Hempacco
two (2) million common shares at $0.075 per share for phase 1 and one (1)
million common shares at $0.075 per share for phase 2 provided that both phases
are completed within 45 days after the agreement date and accepted by Maple
Leaf. The issuance of three (3) million common shares is subject to Maple
Leaf’s Broad of Directors and Neo Stock Exchange's approval.
The Agreement will leverage
Hempacco’s fully integrated supply chain to manufacture, package, market, and
distribute Maple Leaf’s CBG Hemp Cigarettes as well as leveraging Maple Leaf’s
digital branding artwork, expertise in cultivating high quality, organic CBG
Hemp, and its role as a gateway for penetrating international markets. By
utilizing the resources from both Maple Leaf and Hempacco, the Agreement will
disrupt the cigarette industry by providing a naturally great-tasting
alternative to traditional tobacco and nicotine cigarettes. Hemp cigarettes are
also a great alternative to marijuana by offering the non-psychoactive effects
caused by THC with the added benefits of CBG.
Investors can trade these stocks and other ideas on our site using our list of top stock trading
apps including Robinhood , Acorn, Stash and others.
Investor ideas reminds all
listeners to read our disclaimers and disclosures on the Investorideas.com
website and that this podcast is not an endorsement to buy products or services
or securities. Investors are reminded all investment involves risk and possible
loss of investment.
Learn more about
our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
Hear the investor ideas potcast on Spotify
To hear more
Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
Investorideas.com
podcasts are also available on iTunes,
Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified
word mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
About Investorideas.com - News that
Inspires Big Investing Ideas
Investorideas.com
is a recognized news source publishing third party news, research and original
financial content. Learn about investing in stocks and sector trends with our
news alerts, articles, podcasts and
videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water,
renewable energy and more. Investor Idea’s original branded content includes
the following podcasts and columns : Crypto Corner , Play
by Play sports and stock news column, Investor Ideas
Potcasts Cannabis News and Stocks on the Move podcast and
column, Cleantech
and Climate Change , Exploring
Mining the AI
Eye .
Disclaimer/Disclosure: Investorideas.com is a
digital publisher of third party sourced news, articles and equity research as
well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investing involves risk and possible losses. This site is currently
compensated for news publication and distribution, social media and marketing,
content creation and more. Disclosure is posted for each compensated news
release, content published /created if required but otherwise the news was not
compensated for and was published for the sole interest of our readers and followers.
Contact management and IR of each company directly regarding specific
questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other
news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations
of each country. Please read Investorideas.com privacy policy:
https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of
cannabis except where permissible by law. Our site does not possess,
distribute, or sell cannabis products.
Follow us on Twitter https://twitter.com/Investorideas
Follow
us on Facebook https://www.facebook.com/Investorideas
Follow
us on YouTube https://www.youtube.com/c/Investorideas
Download
our Mobile App for
iPhone and Android
Join
our Investor Club https://www.investorideas.com/membership/
Contact Investorideas.com
800
665 0411
Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directory
No comments:
Post a Comment